July JDD Highlights
Below are the issue highlights and Editor Picks for the July issue of JDD!
HDSM-Ax can be used in clinical research and practice to quantify changes in symptom severity in response to treatment in The Hyperhidrosis Disease Severity Measure-Axillary: Conceptualization and Development of Item Content.
The untapped potential of nanotechnology in the treatment of disorders of the skin, hair, and nails where drug delivery remains a challenge is illustrated in Nitric Oxide Releasing Nanoparticles as a Strategy to Improve Current Onychomycosis Treatments
Pariser et al present a multicenter Phase 2 study, Halobetasol 0.01%/Tazarotene 0.045% Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis: Maintenance of Therapeutic Effect After Cessation of Therapy.
Palm and Misell present a split-face study in Topical Transdermally Delivered Lidocaine and Benzocaine Compared to Compounded Lidocaine/Tetracaine During Microfocused Ultrasound With Visualization Treatment.
The Importance of Early Treatment in Psoriasis and Management of Disease Progression discusses key factors in psoriasis progression including the role of systemic inflammation in both psoriasis pathogenesis and development of comorbidities.
A summary of clinical experience from 3 US centers is presented in Primary Axillary Hyperhidrosis Treatment Using High Intensity Focused Fractional Radiofrequency Microneedling.
Dupilumab was compared to usual care with emollients for adults with AD in Economic Evaluation of Dupilumab for Moderate-to-Severe Atopic Dermatitis: A Cost-Utility Analysis.
The clinical characteristics associated with SSI following MMS and WLE performed below the knee are evaluated in Clinical Characteristics of Lower Extremity Surgical Site Infections in Dermatologic Surgery Based Upon 24-Month Retrospective Review.
Combined Hyperthermic 1060nm Diode Laser Lipolysis With Topical Skin Tightening Treatment: Case Series demonstrates that a combined topical skin tightening concentrate with a hyperthermic laser lipolysis device may achieve improved aesthetic outcomes without adverse events.
Editor Picks:
Nitric Oxide Releasing Nanoparticles as a Strategy to Improve Current Onychomycosis Treatments
